Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.320
-0.010 (-0.23%)
At close: Dec 26, 2025, 4:00 PM EST
4.400
+0.080 (1.85%)
After-hours: Dec 26, 2025, 5:53 PM EST
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $243.93 million as of December 26, 2025. Its market cap has increased by 14.18% in one year.
Market Cap
243.93M
Enterprise Value
164.14M
1-Year Change
14.18%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $243.93M, an increase of 23.54%. That is a compound annual growth rate of 3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 243.93M | 60.42% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |